BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33113021)

  • 1. Characterizing the face in facioscapulohumeral muscular dystrophy.
    Loonen TGJ; Horlings CGC; Vincenten SCC; Beurskens CHG; Knuijt S; Padberg GWAM; Statland JM; Voermans NC; Maal TJJ; van Engelen BGM; Mul K
    J Neurol; 2021 Apr; 268(4):1342-1350. PubMed ID: 33113021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Face to Face: deciphering facial involvement in inclusion body myositis.
    Fortanier E; Delmont E; Kouton L; Corazza G; Grapperon AM; Verschueren A; Attarian S; Salort-Campana E
    J Neurol; 2024 Jan; 271(1):410-418. PubMed ID: 37740740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
    Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
    Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.
    Mul K; Lassche S; Voermans NC; Padberg GW; Horlings CG; van Engelen BG
    Pract Neurol; 2016 Jun; 16(3):201-7. PubMed ID: 26862222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
    Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
    Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.
    Lamperti C; Fabbri G; Vercelli L; D'Amico R; Frusciante R; Bonifazi E; Fiorillo C; Borsato C; Cao M; Servida M; Greco F; Di Leo R; Volpi L; Manzoli C; Cudia P; Pastorello E; Ricciardi L; Siciliano G; Galluzzi G; Rodolico C; Santoro L; Tomelleri G; Angelini C; Ricci E; Palmucci L; Moggio M; Tupler R
    Muscle Nerve; 2010 Aug; 42(2):213-7. PubMed ID: 20544930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.
    Wohlgemuth M; Lemmers RJ; Jonker M; van der Kooi E; Horlings CG; van Engelen BG; van der Maarel SM; Padberg GW; Voermans NC
    Neurology; 2018 Jul; 91(5):e444-e454. PubMed ID: 29997197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
    Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
    J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
    Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
    Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.
    Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC
    Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
    Xiao T; Yang H; Gan S; Wu L
    Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
    van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
    Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isokinetic assessment of trunk muscles in facioscapulohumeral muscular dystrophy type 1 patients.
    Esnault J; Missaoui B; Bendaya S; Mane M; Eymard B; Laforet P; Stojkovic T; Behin A; Thoumie P
    Neuromuscul Disord; 2018 Dec; 28(12):996-1002. PubMed ID: 30415787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study.
    Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC
    Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy.
    Ricci G; Cammish P; Siciliano G; Tupler R; Lochmuller H; Evangelista T
    Muscle Nerve; 2019 Jun; 59(6):711-713. PubMed ID: 30895627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.